Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Myeloid 2Classical hematology 2Plasma cell 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 71Leukemia, Lymphocytic, Chronic, B-Cell 62Hodgkin Disease 59Precursor Cell Lymphoblastic Leukemia-Lymphoma 58Myelodysplastic Syndromes 56Lymphoma, Non-Hodgkin 54Multiple Myeloma 52Leukemia 43Lymphoma, Mantle-Cell 40Lymphoma 39Lymphoma, Large B-Cell, Diffuse 37Leukemia, Myelogenous, Chronic, BCR-ABL Positive 37Myeloproliferative Disorders 36Lymphoma, Follicular 36Lymphoma, B-Cell, Marginal Zone 33Leukemia, Myelomonocytic, Chronic 28Burkitt Lymphoma 28Congenital Abnormalities 27Anemia, Refractory, with Excess of Blasts 25Waldenstrom Macroglobulinemia 24Lymphoma, Large-Cell, Immunoblastic 24Leukemia, Myeloid, Chronic-Phase 24Hematologic Neoplasms 23Primary Myelofibrosis 22Leukemia, Myeloid, Accelerated Phase 20Blast Crisis 19Graft vs Host Disease 18Neoplasms, Plasma Cell 17Leukemia, Prolymphocytic 17Leukemia, Myelomonocytic, Juvenile 17

Interventions

Imatinib Mesylate 6Cytarabine 5ponatinib 4nilotinib 4venetoclax 3fludarabine phosphate 3Mycophenolic Acid 3thymoglobulin 2fludarabine 2enasidenib 2Methotrexate 2Lenalidomide 2Cyclosporine 2Cyclophosphamide 2Azacitidine 2Antilymphocyte Serum 2quizartinib 1methanesulfonic acid 1glasdegib 1etoposide phosphate 1daratumumab 1bosutinib 1asciminib 1Whole-Body Irradiation 1Transplantation 1Temozolomide 1Tacrolimus 1Stem Cell Transplantation 1Standard of Care 1RFT5-SMPT-dgA immunotoxin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Leukemia, Myeloid × Mycophenolic Acid × Clear all
NCT01760655 2025-10-30

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

Thomas Jefferson University

Phase 2 Completed
62 enrolled 15 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hodgkin Disease, Leukemia, Myeloid, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Polycythemia Vera, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Primary Myelofibrosis

NCT00568633 2019-09-24

Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

Stanford University

Phase 3 Terminated
58 enrolled 18 charts
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT01392989 2019-05-07

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Stanford University

Phase 2 Completed
44 enrolled 13 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neural Tube Defects

Data powered by HemOnc (CC BY 4.0) Colophon âš¡